Close Menu

Derek Lowe is not a fan of impact factors, and suggests that we all start pretending they just don't exist. But, realistically, he writes, a compromise might be more helpful: "Tell junior faculty and staff that their publication records will be a part of their evaluations, of course. But tell them that they're not the most important part, and that a short publication list can be balanced out by other factors," he writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.